{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:43Z","timestamp":1789499023333,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Prostate cancer (PCa) is a major public health challenge in the United States. This study analyzed the long-term trends in PCa burden from 1990 to 2021 and provides projections for future trends. Data were obtained from the Global Burden of Disease 2021 database to evaluate PCa burden metrics in the United States and globally, including incidence, prevalence, mortality, and disability-adjusted life years. Temporal trends were assessed using joinpoint regression analysis, while age\u2013period\u2013cohort models were applied to evaluate the effects of age, period, and birth cohort. Decomposition analysis was performed to quantify the contributions of population growth, population aging, and epidemiological changes to variations in PCa burden. Future trends through 2036 were projected using a Bayesian age\u2013period\u2013cohort model. Relative to global estimates, the burden of PCa remained higher in the United States throughout the study period. In 2021, PCa imposed a significant burden on males in the United States, particularly among individuals aged 65 to 69. An estimated 2,671,779 prevalent cases, 297,836 incident cases, and 44,032 deaths were recorded. The age-standardized incidence rate and age-standardized prevalence rate in the United States exceeded the corresponding global estimates, reaching 108.04 and 967.87 per 100,000 population, respectively. Although age-standardized rates generally declined between 1990 and 2021, the absolute numbers of incident and prevalent cases continued to increase, indicating that an increasing number of individuals are living with PCa. Among U.S. states, Louisiana had the highest burden, whereas Hawaii had the lowest. Decomposition analysis revealed that population aging and population growth increased the burden of PCa, whereas epidemiological changes partially offset these increases. Projections suggested a gradual increase in the burden of PCa through 2036. These findings highlight the need for targeted public health strategies to reduce the future burden of PCa in the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049525","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:02:20Z","timestamp":1782496940000},"page":"e49525","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term trends in the burden of prostate cancer in the United States from 1990 to 2021: A detailed analysis based on the Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"105","author":[{"given":"Gaowei","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longsheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Operating Room, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinji","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6439-6257","authenticated-orcid":false,"given":"Peidong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260915","doi-asserted-by":"crossref","DOI":"10.1155\/proc\/8839773","article-title":"Prostate cancer mortality in Iranian men during 1990\u20132021: an age\u2013period\u2013cohort and joinpoint regression analysis.","volume":"2025","author":"Jafari","year":"2025","journal-title":"Prostate Cancer"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1177\/1557988318798279","article-title":"Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location.","volume":"12","author":"Taitt","year":"2018","journal-title":"Am J Mens Health"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer.","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bju.16178","article-title":"Global viewpoints: updates on prostate cancer in Sub\u2010Saharan Africa.","volume":"133","author":"Jalloh","year":"2024","journal-title":"BJU Int"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent.","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity \u2013 United States, 2001\u20132017.","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/ijms21041447","article-title":"Influence of diet and nutrition on prostate cancer.","volume":"21","author":"Matsushita","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R9-20260915","first-page":"17","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the global burden of disease study 2021.","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R12-20260915","first-page":"64","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021.","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement.","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s13524-013-0243-z","article-title":"Assessing validity and application scope of the intrinsic estimator approach to the age\u2013period\u2013cohort problem.","volume":"50","author":"Luo","year":"2013","journal-title":"Demography"},{"key":"R16-20260915","first-page":"171","article-title":"Standardization and decomposition of rates from cross-classified data.","volume":"50","author":"Das Gupta","year":"1994","journal-title":"Genus"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: bayesian age\u2013period\u2013cohort analysis with integrated nested Laplace approximations.","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/tau.2020.02.21","article-title":"Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030.","volume":"9","author":"Cai","year":"2020","journal-title":"Transl Androl Urol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the global burden of disease study.","volume":"396","author":"Vollset","year":"2020","journal-title":"Lancet"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/djp122","article-title":"Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.","volume":"101","author":"Cooperberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hpm.3383","article-title":"Assessing the impact of diversity and ageing population on health expenditure of United States.","volume":"37","author":"Amin","year":"2022","journal-title":"Int J Health Plann Manage"},{"key":"R22-20260915","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review.","volume":"48","author":"Perdana","year":"2016","journal-title":"Acta Med Indones"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.urolonc.2019.06.018","article-title":"Diet and lifestyle considerations for patients with prostate cancer.","volume":"38","author":"Zuniga","year":"2020","journal-title":"Urol Oncol"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/nu13020496","article-title":"Dietary factors and prostate cancer development, progression, and reduction.","volume":"13","author":"Oczkowski","year":"2021","journal-title":"Nutrients"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1111\/dom.15924","article-title":"The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021.","volume":"26","author":"Al Ta\u2019ani","year":"2024","journal-title":"Diabetes Obesity Metabol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors \u2013 a systematic review.","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer.","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R28-20260915","first-page":"7","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.eururo.2016.12.026","article-title":"A systematic approach to discussing active surveillance with patients with low-risk prostate cancer.","volume":"71","author":"Ehdaie","year":"2017","journal-title":"Eur Urol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"824464","DOI":"10.3389\/fmed.2022.824464","article-title":"Different trends in the incidence and mortality rates of prostate cancer between China and the USA: a joinpoint and age\u2013period\u2013cohort analysis.","volume":"9","author":"He","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M18-2800","article-title":"Local area variation in morbidity among low-income, older adults in the united states: a cross-sectional study.","volume":"171","author":"Polyakova","year":"2019","journal-title":"Ann Intern Med"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3390\/cancers15071939","article-title":"Rural\u2013urban disparities in patient care experiences among prostate cancer survivors: a SEER-CAHPS study.","volume":"15","author":"Pandit","year":"2023","journal-title":"Cancers"},{"key":"R33-20260915","first-page":"111","article-title":"Cancer statistics for African American and Black people, 2025.","volume":"75","author":"Saka","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41391-022-00628-0","article-title":"Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database.","volume":"26","author":"Jani","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:10:54Z","timestamp":1789495854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":34,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049525","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2026-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}